Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S B (OP:NONOF)

50.34 +2.24 (+4.67%)
Streaming Delayed Price Updated: 10:55 AM EST, Feb 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,497
Open 49.50
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 48.09
Today's Range 48.46 - 51.19
52wk Range 40.25 - 93.83
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Novo Nordisk's Wegovy Demonstrates Greater Weight Loss In Women With Heart Condition ↗
The greater weight loss in women did not result in significantly better improvements in heart failure symptoms. 
Via Benzinga
News headline image
Move Aside Ozempic, WeGovy: Denmark's New Drug Just Showed Positive Results For Weightloss ↗
As per the official press release, the 16-week trial aimed to evaluate the safety, tolerability, and clinical effects of the drug called petrelintide. 
Via Benzinga

Performance

YTD
-4.6%
-4.6%
1 Month
-14.7%
-14.7%
3 Month
+7.7%
+7.7%
6 Month
+1.5%
+1.5%
1 Year
-41.3%
-41.3%

More News

Read More
News headline image
The Dividend Darlings: 3 Stocks That Will Shower Your Portfolio with Cash ↗
Via InvestorPlace
News headline image
Novo Nordisk's Wegovy Delivers: Long-Term Study Shows Sustained Weight Loss As Drugmaker Tries To Woo Insurers And Governments ↗
Via Benzinga
News headline image
7 Mutual Funds That Will Outperform in Any Market ↗
Via InvestorPlace
News headline image
Did Ozempic Play A Role In A Man's Suicide? Family Seeks Warning Label ↗
Via Benzinga
News headline image
Emmanuel Macron To Unveil Novo Nordisk Record $2.3B Investment In France's Health Sector ↗
Via Benzinga
News headline image
Experts Weigh In On Ozempic's Evolving Side Effects And How To Handle Them ↗
Via Benzinga
News headline image
Diabetes Drug Ozempic May Hold Key to Breaking Addictions: The Guardian ↗
Via Benzinga
News headline image
Icannex Taps Ex Pfizer, FDA & Regulatory Affairs Expert ↗
Via Benzinga

Frequently Asked Questions

Is Novo Nordisk A/S B publicly traded?
Yes, Novo Nordisk A/S B is publicly traded.
What exchange does Novo Nordisk A/S B trade on?
Novo Nordisk A/S B trades on the OTC Traded
What is the ticker symbol for Novo Nordisk A/S B?
The ticker symbol for Novo Nordisk A/S B is NONOF on the OTC Traded
What is the current price of Novo Nordisk A/S B?
The current price of Novo Nordisk A/S B is 50.34
When was Novo Nordisk A/S B last traded?
The last trade of Novo Nordisk A/S B was at 02/09/26 10:55 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.